Boni E. Elewski

18.0k total citations · 2 hit papers
291 papers, 10.5k citations indexed

About

Boni E. Elewski is a scholar working on Epidemiology, Dermatology and Cell Biology. According to data from OpenAlex, Boni E. Elewski has authored 291 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Epidemiology, 107 papers in Dermatology and 75 papers in Cell Biology. Recurrent topics in Boni E. Elewski's work include Nail Diseases and Treatments (156 papers), Fungal Infections and Studies (91 papers) and Plant Pathogens and Fungal Diseases (72 papers). Boni E. Elewski is often cited by papers focused on Nail Diseases and Treatments (156 papers), Fungal Infections and Studies (91 papers) and Plant Pathogens and Fungal Diseases (72 papers). Boni E. Elewski collaborates with scholars based in United States, Canada and Italy. Boni E. Elewski's co-authors include Mahmoud A. Ghannoum, K. Wade Foster, David M. Pariser, Mark Lebwohl, Kim Papp, Phoebe Rich, Richard G. Langley, Bárður Sigurgeirsson, Antonellá Tosti and Aditya K. Gupta and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Gastroenterology.

In The Last Decade

Boni E. Elewski

286 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

2014 1.5k citations Richard G. Langley, Boni E. Elewski et al. profile →
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

2020 213 citations Jonathan I. Silverberg, D. Toth et al. British Journal of Dermatology profile →

Peers

Countries citing papers authored by Boni E. Elewski

Since Specialization

Citations

This map shows the geographic impact of Boni E. Elewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boni E. Elewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boni E. Elewski more than expected).

Fields of papers citing papers by Boni E. Elewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boni E. Elewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boni E. Elewski. The network helps show where Boni E. Elewski may publish in the future.

Co-authorship network of co-authors of Boni E. Elewski

This figure shows the co-authorship network connecting the top 25 collaborators of Boni E. Elewski. A scholar is included among the top collaborators of Boni E. Elewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boni E. Elewski. Boni E. Elewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	51782 Generalized pustular psoriasis (GPP) continues to adversely impact quality of life between flares, as per Dermatology Life Quality Index scores: Baseline data from the Effisayil 2 trial 2024 ·Journal of the American Academy of Dermatology ·Matthias Augustin, Alice B. Gottlieb, Yayoi Tada, L. Puig, Boni E. Elewski, Melinda Gooderham, Richard B. Warren, Ming Tang, Patrick Hofmann, Christian Thoma, April W. Armstrong	1
2	Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials 2024 ·Dermatology and Therapy ·Joseph F. Merola, Alice B. Gottlieb, Andreas Pinter, Boni E. Elewski, Melinda Gooderham, Richard B. Warren, Stefano Piaserico, (unknown), Nancy Cross, Nicola Tilt, (unknown), Ulrich Mrowietz	2
3	Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison 2024 ·Dermatology and Therapy ·(unknown), (unknown), Warren S. Joseph, Boni E. Elewski, Mahmoud A. Ghannoum	3
4	CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa 2024 ·Proceedings of the National Academy of Sciences ·Mahendra Kashyap, Bharat Mishra, R. Sinha, Lin Jin, (unknown), Nilesh Kumar, Kayla F. Goliwas, (unknown), Jessy S. Deshane, Erik Berglund, David Berglund, Boni E. Elewski, Craig A. Elmets, Mohammad Athar, (unknown), Chander Raman	3
5	43751 Efficacy and safety of spesolimab for generalized pustular psoriasis treatment according to flare trigger 2023 ·Journal of the American Academy of Dermatology ·Claudia de la Cruz, Akimichi Morita, Boni E. Elewski, Kamran Ghoreschi, (unknown), (unknown), Christian Thoma, Siew Eng Choon	1
6	Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study 2023 ·Journal of the American Academy of Dermatology ·Boni E. Elewski, Mark Lebwohl, Milan J. Anadkat, Juliet N. Barker, Kamran Ghoreschi, Shinichi Imafuku, Ulrich Mrowietz, Ling Li, Manuel Quaresma, Christian Thoma, H. Bachelez	21
7	Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa 2023 ·Proceedings of the National Academy of Sciences ·Lin Jin, Yunjia Chen, Suhail Muzaffar, Chao Li, (unknown), Jasim Khan, Mahendra Kashyap, Shanrun Liu, Ritesh K. Srivastava, Jessy S. Deshane, Tim M. Townes, Boni E. Elewski, Craig A. Elmets, David K. Crossman, Chander Raman, Mohammad Athar	10
8	Hidradenitis Suppurativa and Five Key Vitamins and Minerals 2023 ·Skin Appendage Disorders ·(unknown), (unknown), (unknown), (unknown), (unknown), Boni E. Elewski, (unknown)	3
9	New Onset Generalized Pustular Psoriasis Rapidly Improved with IL-36 Blockade 2023 ·SKIN The Journal of Cutaneous Medicine ·(unknown), (unknown), (unknown), (unknown), Boni E. Elewski	2
10	Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds 2023 ·Journal of the American Podiatric Medical Association ·Ahmed Gamal, Mohammed Elshaer, Lisa Long, Thomas S. McCormick, Boni E. Elewski, Mahmoud A. Ghannoum	6
11	A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* 2020 ·British Journal of Dermatology ·Andrew Blauvelt, C. Leonardi, Boni E. Elewski, Jeffrey Crowley, Lyn Guenther, Melinda Gooderham, Richard G. Langley, Ronald Vender, Andreas Pinter, C.E.M. Griffiths, Yayoi Tada, Hany Elmaraghy, Renata Gontijo Lima, Gaia Gallo, L. Renda, Russel Burge, (unknown), Baojin Zhu, Kim Papp, (unknown)	73
12	Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial* breakdown → 2020 ·British Journal of Dermatology ·Jonathan I. Silverberg, D. Toth, Thomas Bieber, Andrew Alexis, Boni E. Elewski, Andrew Pink, DirkJan Hijnen, (unknown), B K Bang, C.K. Olsen, Azra Kurbasic, Stephan Weidinger, (unknown)	213
13	Treatment of Tinea Capitis 2019 ·Skin Appendage Disorders ·(unknown), Wendy Cantrell, Boni E. Elewski	34
14	Interest in cosmetic improvement as a marker for tanning behavior: a survey of 1602 respondents 2011 ·Journal of Cosmetic Dermatology ·(unknown), Jamie DeCoster, (unknown), Wendy Cantrell, Craig A. Elmets, Boni E. Elewski	5
15	Advances in Topical and Systemic Antifungals 2007 ·Dermatologic Clinics ·(unknown), (unknown), Boni E. Elewski	68
16	Cutaneous Fungal Infections in the Elderly 2002 ·Clinics in Geriatric Medicine ·(unknown), Boni E. Elewski	9
17	Cutaneous mycoses in children 1996 ·British Journal of Dermatology ·Boni E. Elewski	48
18	Hemodynamic and humoral changes induced by pinacidil a new vasodilator drug in mild to moderate hypertensives 1985 ·Clinical Pharmacology & Therapeutics ·R Fariello, C Alicandri, Boni E. Elewski, Augusto Zaninelli, G Muiesan	2
19	Eruptive Lesions and Malignancy 1985 ·International Journal of Dermatology ·Boni E. Elewski, (unknown)	15
20	Effects of prizidilol skf 92657 on hemodynamics catecholamines and the renin aldo sterone angiotensin system in essential hypertensive patients 1984 ·Clinical Trials ·R Fariello, M.L. Muiesan, C Alicandri, (unknown), E. Agabiti Rosei, (unknown), (unknown), Maurizio Castellano, Boni E. Elewski	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact